Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

Claire Kane from Airdrie lost 18st 7.5lbs through Slimming World after struggling with PCOS and endometriosis, becoming Woman ...

By Vijay Kumar Malesu A new synthesis of randomized trials reveals that a carefully supervised very low-carbohydrate ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...